Literature DB >> 20921622

Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.

Kirsten M L Hertoghs1, Perry D Moerland, Amber van Stijn, Ester B M Remmerswaal, Sila L Yong, Pablo J E J van de Berg, S Marieke van Ham, Frank Baas, Ineke J M ten Berge, René A W van Lier.   

Abstract

CD8+ T cells play a critical role in the immune response to viral pathogens. Persistent human cytomegalovirus (HCMV) infection results in a strong increase in the number of virus-specific, quiescent effector-type CD8+ T cells with constitutive cytolytic activity, but the molecular pathways involved in the induction and maintenance of these cells are unknown. We show here that HCMV infection induced acute and lasting changes in the transcriptomes of virus-reactive T cells collected from HCMV-seropositive patients at distinct stages of infection. Enhanced cell cycle and metabolic activity was restricted to the acute phase of the response, but at all stages, HCMV-specific CD8+ T cells expressed the Th1-associated transcription factors T-bet (TBX21) and eomesodermin (EOMES), in parallel with continuous expression of IFNG mRNA and IFN-γ-regulated genes. The cytolytic proteins granzyme B and perforin as well as the fractalkine-binding chemokine receptor CX3CR1 were found in virus-reactive cells throughout the response. During HCMV latency, virus-specific CD8+ T cells lacked the typical features of exhausted cells found in other chronic infections. Persistent effector cell traits together with the permanent changes in chemokine receptor usage of virus-specific, nonexhausted, long-lived CD8+ T cells may be crucial to maintain lifelong protection from HCMV reactivation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921622      PMCID: PMC2964975          DOI: 10.1172/JCI42758

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  81 in total

1.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; E John Wherry; Sarah A Longworth; John T Northrup; Vikram R Palanivel; Alan C Mullen; Christopher R Gasink; Susan M Kaech; Joseph D Miller; Laurent Gapin; Kenneth Ryan; Andreas P Russ; Tullia Lindsten; Jordan S Orange; Ananda W Goldrath; Rafi Ahmed; Steven L Reiner
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

2.  Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.

Authors:  Naofumi Takemoto; Andrew M Intlekofer; John T Northrup; E John Wherry; Steven L Reiner
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 3.  The case for Survivin as mitotic regulator.

Authors:  Susanne M A Lens; Gerben Vader; René H Medema
Journal:  Curr Opin Cell Biol       Date:  2006-09-07       Impact factor: 8.382

4.  Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages.

Authors:  Cataldo Martucci; Silvia Franchi; Elisa Giannini; Hui Tian; Pietro Melchiorri; Lucia Negri; Paola Sacerdote
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

5.  Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin.

Authors:  Hong Li; Tim Oliver; Wei Jia; You-Wen He
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

6.  Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance.

Authors:  Axel Kallies; Edwin D Hawkins; Gabrielle T Belz; Donald Metcalf; Mirja Hommel; Lynn M Corcoran; Philip D Hodgkin; Stephen L Nutt
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

7.  Transcriptional repressor Blimp-1 regulates T cell homeostasis and function.

Authors:  Gislâine A Martins; Luisa Cimmino; Miriam Shapiro-Shelef; Matthias Szabolcs; Alan Herron; Erna Magnusdottir; Kathryn Calame
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

8.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

9.  Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung.

Authors:  Godelieve J de Bree; Ester M M van Leeuwen; Theo A Out; Henk M Jansen; René E Jonkers; René A W van Lier
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

10.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

Authors:  Constantinos Petrovas; Joseph P Casazza; Jason M Brenchley; David A Price; Emma Gostick; William C Adams; Melissa L Precopio; Timothy Schacker; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

View more
  91 in total

1.  Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Authors:  Dan A Erkes; Guangwu Xu; Constantine Daskalakis; Katherine A Zurbach; Nicole A Wilski; Toktam Moghbeli; Ann B Hill; Christopher M Snyder
Journal:  Mol Ther       Date:  2016-06-10       Impact factor: 11.454

2.  CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Authors:  Benoît P Nicolet; Aurélie Guislain; Floris P J van Alphen; Raquel Gomez-Eerland; Ton N M Schumacher; Maartje van den Biggelaar; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

Review 3.  The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Miriam Ciáurriz; Amaya Zabalza; Lorea Beloki; Cristina Mansilla; Estela Pérez-Valderrama; Mercedes Lachén; Eva Bandrés; Eduardo Olavarría; Natalia Ramírez
Journal:  Cell Mol Life Sci       Date:  2015-07-15       Impact factor: 9.261

4.  Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.

Authors:  Adam R Hersperger; Jeffrey N Martin; Lucy Y Shin; Prameet M Sheth; Colin M Kovacs; Gabriela L Cosma; George Makedonas; Florencia Pereyra; Bruce D Walker; Rupert Kaul; Steven G Deeks; Michael R Betts
Journal:  Blood       Date:  2011-02-02       Impact factor: 22.113

Review 5.  The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation.

Authors:  Nan-ping Weng; Yasuto Araki; Kalpana Subedi
Journal:  Nat Rev Immunol       Date:  2012-03-16       Impact factor: 53.106

Review 6.  Viewing transplantation immunology through today's lens: new models, new imaging, and new insights.

Authors:  Alex Y Huang; W Nicholas Haining; Deborah S Barkauskas; Jay T Myers; Agne Petrosiute; Aneesah P Garrett; Karnail Singh; Kenneth R Cooke; Leslie S Kean
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-22       Impact factor: 5.742

Review 7.  Programmed T cell differentiation: Implications for transplantation.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Cell Immunol       Date:  2020-03-29       Impact factor: 4.868

8.  Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.

Authors:  M M Imanguli; E W Cowen; J Rose; S Dhamala; W Swaim; S Lafond; B Yagi; R E Gress; S Z Pavletic; F T Hakim
Journal:  Leukemia       Date:  2014-02-28       Impact factor: 11.528

9.  Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients.

Authors:  L Huang; A W Langerak; C C Baan; N H R Litjens; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2016-08-19       Impact factor: 4.330

10.  Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.

Authors:  Travis A Doering; Alison Crawford; Jill M Angelosanto; Michael A Paley; Carly G Ziegler; E John Wherry
Journal:  Immunity       Date:  2012-11-15       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.